RURO Announces Limfinity® ML – Machine Learning Module For Limfinity®
December 12, 2018
RURO, Inc., a leading provider of LIMS, LIS, RFID and other life science software solutions, announces the Limfinity® ML (Machine Learning) addition for its Limfinity® 7 framework. Adding Limfinity® ML to a Limfinity® solution is a straightforward processing including the configuration of input and output data fields. With continued use, trained models may capture relationships [...]
December 12, 2018
OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamics track plots and advanced collaboration capabilities SAN DIEGO -- OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active Motif to improve accuracies in data analysis for ChIP-Seq experiments. OnRamp’s flagship [...]
LabsUSA Selected to Supply Lab Equipment and Lab Furniture for New Material Testing Laboratory
December 12, 2018
LabsUSA of Salt Lake City was recently selected by Dyad Labs to provide the lab furniture the lab equipment for Dyad Labs when they established a new material testing laboratory. Salt Lake City, Utah - Dyad Labs selected LabsUSA for the design and layout of the lab furniture and equipment needed for a new material testing [...]
LGC acquires M.B.H. Analytical
December 12, 2018
LGC has announced that it has acquired M.B.H. Analytical Limited, (MBH) a leading manufacturer of metal alloy reference materials (RMs). Located in Barnet, north London, MBH was founded in 1973 and is certified to ISO 9001:2015. Its RMs are used globally for quality control testing and material validation, including positive materials identification testing, in a [...]
December 12, 2018
Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon®Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery. “We are committed to raising the height of our innovation by adopting new technologies that make drug discovery and development more [...]
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
December 12, 2018
BERKELEY, CA – Caribou Biosciences, Inc., a leading genome editing company, announced today that it has appointed Natalie Sacks, MD to its Board of Directors. Dr. Sacks is an accomplished industry leader and oncology expert who has played a key role in the development and approval of several oncology therapeutics. “We are excited to welcome [...]
Clustermarket Taps in to GE Healthcare Life Sciences Customers to Reach UK Innovators
December 11, 2018
Clustermarket, the leading UK online scientific equipment sharing and booking platform, has enlisted the support of GE Healthcare’s Life Sciences business in an agreement aimed at helping innovators in the UK access specialized life sciences and biotech equipment. LONDON Clustermarket’s platform will allow owners of GE Healthcare Life Sciences instruments to hire out and maximize [...]
December 11, 2018
BOSTON -- Allotrope Foundation, an international consortium of fourteen global biopharmaceutical companies, has selected TetraScience as their technology partner to standardize chromatography data captured by Waters Empower™ 3 Software through conversion to the Allotrope Data Format (ADF) for an Allotrope Community Project. Empower is Waters Corporation premier chromatography data system (CDS) with thousands of customers across [...]
BC Platforms and Medaffcon Join Forces to Streamline Collaboration Between Biobanks and Researchers
December 11, 2018
BC Platforms AG, a world leader in genomic data management and analytics, today announces that it has partnered with Medaffcon Oy, a company specialized in generating Real World Evidence for health-related decision-making. Medaffcon provides medical, scientific and market access services to international pharmaceutical and biotechnology industries as well as health care operators. The partnership focuses [...]
Schrödinger and TB Alliance Announce Collaboration to Accelerate Tuberculosis Drug Discovery
December 11, 2018
Partnership merges Schrödinger’s advanced modeling capabilities with TB Alliance’s expertise in tuberculosis biology to accelerate the development of next-generation treatments NEW YORK – Dec. 11, 2018 - Schrödinger and TB Alliance today announced a three-year research collaboration to speed the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced computational platform for drug discovery. The [...]

